Apyx Medical Gross Margin 2010-2024 | APYX
Current and historical gross margin for Apyx Medical (APYX) over the last 10 years. The current gross profit margin for Apyx Medical as of September 30, 2024 is %.
| Apyx Medical Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2024-09-30 | $0.05B | $0.03B | 60.42% |
| 2024-06-30 | $0.05B | $0.03B | 61.22% |
| 2024-03-31 | $0.05B | $0.03B | 62.75% |
| 2023-12-31 | $0.05B | $0.03B | 64.15% |
| 2023-09-30 | $0.05B | $0.03B | 64.71% |
| 2023-06-30 | $0.05B | $0.03B | 64.58% |
| 2023-03-31 | $0.04B | $0.03B | 65.91% |
| 2022-12-31 | $0.04B | $0.03B | 65.91% |
| 2022-09-30 | $0.05B | $0.03B | 68.75% |
| 2022-06-30 | $0.05B | $0.04B | 68.63% |
| 2022-03-31 | $0.05B | $0.04B | 69.23% |
| 2021-12-31 | $0.05B | $0.03B | 69.39% |
| 2021-09-30 | $0.04B | $0.03B | 69.77% |
| 2021-06-30 | $0.04B | $0.03B | 71.05% |
| 2021-03-31 | $0.03B | $0.02B | 67.74% |
| 2020-12-31 | $0.03B | $0.02B | 66.67% |
| 2020-09-30 | $0.02B | $0.02B | 66.67% |
| 2020-06-30 | $0.03B | $0.02B | 64.00% |
| 2020-03-31 | $0.03B | $0.02B | 67.86% |
| 2019-12-31 | $0.03B | $0.02B | 68.97% |
| 2019-09-30 | $0.03B | $0.02B | 66.67% |
| 2019-06-30 | $0.02B | $0.02B | 69.57% |
| 2019-03-31 | $0.02B | $0.01B | 70.00% |
| 2018-12-31 | $0.02B | $0.01B | 70.59% |
| 2018-09-30 | $0.02B | $0.01B | 73.33% |
| 2018-06-30 | $0.01B | $0.01B | 71.43% |
| 2018-03-31 | $0.02B | $0.01B | 60.00% |
| 2017-12-31 | $0.03B | $0.01B | 56.00% |
| 2017-09-30 | $0.03B | $0.02B | 53.33% |
| 2017-06-30 | $0.04B | $0.02B | 51.35% |
| 2017-03-31 | $0.04B | $0.02B | 52.78% |
| 2016-12-31 | $0.04B | $0.02B | 50.00% |
| 2016-09-30 | $0.04B | $0.02B | 48.57% |
| 2016-06-30 | $0.03B | $0.02B | 45.45% |
| 2016-03-31 | $0.03B | $0.01B | 41.94% |
| 2015-12-31 | $0.03B | $0.01B | 44.83% |
| 2015-09-30 | $0.03B | $0.01B | 39.29% |
| 2015-06-30 | $0.03B | $0.01B | 37.04% |
| 2015-03-31 | $0.03B | $0.01B | 33.33% |
| 2014-12-31 | $0.03B | $0.01B | 33.33% |
| 2014-09-30 | $0.03B | $0.01B | 38.46% |
| 2014-06-30 | $0.03B | $0.01B | 40.00% |
| 2014-03-31 | $0.02B | $0.01B | 41.67% |
| 2013-12-31 | $0.02B | $0.01B | 37.50% |
| 2013-09-30 | $0.03B | $0.01B | 36.00% |
| 2013-06-30 | $0.03B | $0.01B | 38.46% |
| 2013-03-31 | $0.03B | $0.01B | 40.74% |
| 2012-12-31 | $0.03B | $0.01B | 42.86% |
| 2012-09-30 | $0.03B | $0.01B | 44.44% |
| 2012-06-30 | $0.03B | $0.01B | 46.15% |
| 2012-03-31 | $0.03B | $0.01B | 46.15% |
| 2011-12-31 | $0.03B | $0.01B | 44.00% |
| 2011-09-30 | $0.03B | $0.01B | 44.00% |
| 2011-06-30 | $0.03B | $0.01B | 42.31% |
| 2011-03-31 | $0.03B | $0.01B | 40.00% |
| 2010-12-31 | $0.03B | $0.01B | 40.00% |
| 2010-09-30 | $0.03B | $0.01B | 38.46% |
| 2010-06-30 | $0.03B | $0.01B | 40.00% |
| 2010-03-31 | $0.03B | $0.01B | 42.31% |
| 2009-12-31 | $0.03B | $0.01B | 44.44% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.055B | $0.052B |
| Apyx Medical Corporation is an energy technology company. It provides products in the cosmetic and surgical markets. The company's Helium Plasma Technology is marketed and sold as Renuvion(R) in the cosmetic surgery market and J-Plasma(R) in the hospital surgical market. Apyx Medical Corporation, formerly known as Bovie Medical Corporation, is based in FL, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $230.977B | 28.52 |
| Boston Scientific (BSX) | United States | $155.488B | 41.98 |
| Stryker (SYK) | United States | $147.446B | 31.70 |
| EssilorLuxottica (ESLOY) | France | $140.780B | 0.00 |
| Medtronic (MDT) | Ireland | $112.764B | 16.47 |
| Lonza Group Ag (LZAGY) | Switzerland | $47.084B | 0.00 |
| Haleon (HLN) | United Kingdom | $44.818B | 29.12 |
| GE HealthCare Technologies (GEHC) | United States | $42.113B | 20.51 |
| Agilent Technologies (A) | United States | $39.025B | 25.86 |
| ResMed (RMD) | United States | $34.189B | 26.33 |
| Terumo (TRUMY) | Japan | $26.310B | 37.41 |
| Koninklijke Philips (PHG) | Netherlands | $23.527B | 16.80 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.630B | 12.95 |
| Insulet (PODD) | United States | $20.222B | 86.57 |
| Baxter (BAX) | United States | $17.074B | 12.34 |
| Sunny Optical Technology (SNPTF) | China | $11.331B | 0.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.245B | 0.00 |
| BellRing Brands (BRBR) | United States | $9.513B | 35.65 |
| Bio-Rad Laboratories (BIO) | United States | $8.001B | 27.70 |
| Demant (WILYY) | Denmark | $7.946B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $5.621B | 13.06 |
| Prestige Consumer Healthcare (PBH) | United States | $4.200B | 20.05 |
| ICU Medical (ICUI) | United States | $3.995B | 38.03 |
| Envista Holdings (NVST) | United States | $3.693B | 29.38 |
| Perrigo (PRGO) | Ireland | $3.443B | 10.14 |
| Haemonetics (HAE) | United States | $3.188B | 15.00 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $2.989B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.921B | 19.69 |
| QuidelOrtho (QDEL) | United States | $2.760B | 23.18 |
| LeMaitre Vascular (LMAT) | United States | $2.269B | 55.15 |
| Neogen (NEOG) | United States | $2.178B | 25.10 |
| AtriCure (ATRC) | United States | $1.914B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.484B | 25.90 |
| InMode (INMD) | Israel | $1.320B | 11.03 |
| BioLife Solutions (BLFS) | United States | $1.276B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.180B | 8.43 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.997B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.938B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.930B | 14.27 |
| Evolus (EOLS) | United States | $0.926B | 0.00 |
| CeriBell (CBLL) | United States | $0.828B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.689B | 0.00 |
| Valneva SE (VALN) | France | $0.643B | 0.00 |
| Omeros (OMER) | United States | $0.557B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.529B | 22.95 |
| Owens & Minor (OMI) | United States | $0.494B | 3.86 |
| Surmodics (SRDX) | United States | $0.492B | 0.00 |
| SNDL (SNDL) | Canada | $0.462B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.459B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.373B | 0.00 |
| ZimVie (ZIMV) | United States | $0.368B | 30.98 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.349B | 0.00 |
| Cerus (CERS) | United States | $0.323B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.321B | 58.60 |
| Viemed Healthcare (VMD) | United States | $0.310B | 29.52 |
| Sanara MedTech (SMTI) | United States | $0.309B | 0.00 |
| Quanterix (QTRX) | United States | $0.292B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.289B | 19.40 |
| Biote (BTMD) | United States | $0.260B | 5.69 |
| Canopy Growth (CGC) | Canada | $0.250B | 0.00 |
| Zynex (ZYXI) | United States | $0.236B | 49.40 |
| Sanuwave Health (SNWV) | United States | $0.231B | 3.24 |
| Brainsway (BWAY) | Israel | $0.212B | 112.80 |
| High Tide (HITI) | Canada | $0.209B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.206B | 15.39 |
| MacroGenics (MGNX) | United States | $0.181B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.174B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.163B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.160B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.140B | 17.51 |
| Jin Medical (ZJYL) | China | $0.124B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.112B | 0.00 |
| Fonar (FONR) | United States | $0.091B | 12.79 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Veru (VERU) | United States | $0.086B | 0.00 |
| InterCure (INCR) | Israel | $0.075B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.067B | 0.00 |
| Exagen (XGN) | United States | $0.067B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.063B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.058B | 30.00 |
| Hongchang (HCIL) | China | $0.051B | 0.00 |
| MariMed (MRMD) | United States | $0.050B | 0.00 |
| United-Guardian (UG) | United States | $0.050B | 14.22 |
| ImmuCell (ICCC) | United States | $0.045B | 0.00 |
| Modular Medical (MODD) | United States | $0.044B | 0.00 |
| INLIF (INLF) | $0.040B | 0.00 | |
| Safety Shot (SHOT) | United States | $0.031B | 0.00 |
| Nephros (NEPH) | United States | $0.016B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.015B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.012B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.009B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Sharps Technology (STSS) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |